Log in to your Inderes Free account to see all free content on this page.
Peptonic Medical
0.00 SEK
0.00 %
Less than 1K followers
PMED
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Peptonic Medical
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 4.4 | 21.3 | 31.6 | 43.6 | 37.1 | 26.9 | 14.8 |
| growth-% | 382.8 % | 48.7 % | 37.9 % | -14.9 % | -27.6 % | -45.0 % | |
| EBITDA | -21.1 | -27.8 | -46.7 | -30.1 | -34.9 | -52.0 | -13.7 |
| EBIT | -23.9 | -31.1 | -73.7 | -33.6 | -41.2 | -58.7 | -19.4 |
| Profit before taxes | -24.5 | -31.3 | -73.7 | -36.9 | -42.6 | -60.0 | -22.5 |
| Net income | -24.5 | -31.1 | -73.7 | -36.9 | -42.6 | -60.0 | -22.5 |
| EPS | -0.08 | -0.08 | -0.16 | -0.06 | -0.03 | -0.02 | 0.00 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -477.9 % | -130.5 % | -147.5 % | -69.0 % | -94.0 % | -193.2 % | -92.6 % |
| EBIT-% | -542.7 % | -145.9 % | -233.0 % | -77.0 % | -110.9 % | -218.1 % | -131.5 % |
| ROE | -28.6 % | -26.4 % | -141.7 % | -78.3 % | -56.5 % | -123.6 % | -58.8 % |
| ROI | -26.7 % | -23.1 % | -88.2 % | -43.0 % | -39.9 % | -85.1 % | -34.1 % |
Login required
This content is only available for logged in users